Annotation Detail for DLX5
Basic Information Top
Gene Symbol: | DLX5 ( - ) |
---|---|
Gene Full Name: | distal-less homeobox 5 |
Band: | 7q21.3 |
Quick Links | Entrez ID:1749; OMIM: 600028; Uniprot ID:DLX5_HUMAN; ENSEMBL ID: ENSG00000105880; HGNC ID: 2918 |
Relate to Another Database: | SFARIGene; denovo-db |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C014949 | acetylhydrazine | acetylhydrazine results in decreased expression of DLX5 mRNA | decreases expression | 15282401 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of DLX5 mRNA | affects expression | 16483693 |
D001374 | Azacitidine | Azacitidine results in increased expression of DLX5 mRNA | increases expression | 17085970 |
C006780 | bisphenol A | bisphenol A results in decreased expression of DLX5 mRNA | decreases expression | 12075121 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of DLX5 mRNA | decreases expression | 16239168 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of DLX5 mRNA | affects expression | 17555576 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of DLX5 mRNA | increases expression | 17942748 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DLX5 mRNA | affects cotreatment|increases expression | 17942748 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of DLX5 mRNA | decreases expression | 12075121 |
D019833 | Genistein | Genistein results in decreased expression of DLX5 mRNA | decreases expression | 12075121 |
D007657 | Ketone Bodies | Ketone Bodies results in decreased expression of DLX5 mRNA | decreases expression | 16807920 |
C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of DLX5 mRNA | increases expression | 17616710 |
C025589 | ochratoxin A | ochratoxin A results in decreased expression of DLX5 mRNA | decreases expression | 20036863 |
D013629 | Tamoxifen | Tamoxifen affects the expression of DLX5 mRNA | affects expression | 17555576 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DLX5 mRNA | affects cotreatment|increases expression | 17942748 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of DLX5 mRNA | increases expression | 17586704 16962184 20130022 17942748 |
D014212 | Tretinoin | Tretinoin results in decreased expression of DLX5 protein | decreases expression | 17551590 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 4.68 | 14745880 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 2.96 | 15322242 14514962 11752688 | |
MESH:D000138 | Acidosis | Ammonium Chloride | 3.68 | 18287403 | |
MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 4.08 | 17505938 | |
MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 4.42 | 14692618 | |
MESH:D000230 | Adenocarcinoma | Genistein | 4.42 | 11473722 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 3.49 | 16835633 | |
MESH:D000505 | Alopecia | Tretinoin | 3.68 | 15955085 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 3.02 | 11748828 | |
MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 3.57 | 11256880 | |
MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 7.37 | 15885639 | |
MESH:D001169 | Arthritis, Experimental | Tretinoin | 7.37 | 16412693 | |
MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 2.28 | 16292516 | |
MESH:D001249 | Asthma | Tretinoin | 2.36 | 16456186 | |
MESH:D001471 | Barrett Esophagus | Tretinoin | 4.50 | 16935849 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 9.21 | 12125929 | |
MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 9.21 | 16206674 16197459 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 3.92 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | marker/mechanism | 10433909 | ||
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.81 | 15746008 | |
MESH:D001862 | Bone Resorption | bisphenol A | 3.94 | 11985600 | |
MESH:D001943 | Breast Neoplasms | bisphenol A | 3.00 | 17123778 | |
MESH:D001943 | Breast Neoplasms | Genistein | 3.00 | 16541309 16873071 17200150 | |
MESH:D001943 | Breast Neoplasms | ochratoxin A | 3.00 | 11921183 | |
MESH:D001943 | Breast Neoplasms | Tamoxifen | 3.00 | 19189212 19288272 19142967 21152245 20544844 19244106 15565566 17261762 18629630 16873071 15668708 17049068 19084267 19200415 18855134 19221464 19189210 18821012 19115204 19487384 19155303 19066611 16202921 17440819 18351453 20065188 11161223 19410462 19103187 18997820 20135344 16818667 20005174 20859285 18984771 19289846 18425577 19059307 21138602 16273361 17893378 19011961 20390343 18815881 17242785 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 3.00 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Tretinoin | 3.00 | 16166294 16443354 16873071 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 4.71 | 16813970 | |
MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 3.88 | 15673190 16124888 16227642 16097048 18705752 15721981 10355542 15700767 16011737 16192424 16050911 3786805 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.86 | 16835633 | |
MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 4.61 | 19066611 | |
MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 5.29 | 16168501 | |
MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 6.69 | 18788625 | |
MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 6.69 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 6.69 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 6.69 | 1917145 | |
MESH:D002278 | Carcinoma in Situ | bisphenol A | 5.11 | 17123778 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 2.31 | 16096774 16051514 | |
MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 3.69 | 17572228 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 2.41 | 16120746 18850075 18670907 | |
MESH:D002318 | Cardiovascular Diseases | Genistein | 3.36 | 16332659 | |
MESH:D002386 | Cataract | Tretinoin | 3.14 | 17460283 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 4.71 | 16129372 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 3.23 | 16835633 | |
MESH:D002779 | Cholestasis | Ethinyl Estradiol | 2.93 | 16919318 17333356 17681005 11677210 17110522 15861022 16105132 | |
MESH:D002822 | Choriocarcinoma | Tretinoin | 5.29 | 16461808 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 5.87 | 16354765 8697196 15668235 15340226 12621046 | |
MESH:D002972 | Cleft Palate | Tretinoin | 5.87 | 9407595 | |
MESH:D003092 | Colitis | Tretinoin | 3.81 | 17035595 | |
MESH:D003110 | Colonic Neoplasms | Genistein | 2.30 | 17182828 | |
MESH:D015179 | Colorectal Neoplasms | Azacitidine | 2.72 | 19934284 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 3.13 | 14669216 17141729 | |
MESH:D019465 | Craniofacial Abnormalities | marker/mechanism | 10433909 10433912 14666512 | ||
MESH:D019465 | Craniofacial Abnormalities | ochratoxin A | 3.98 | 20036863 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 3.98 | 15322242 10048152 20055451 | |
MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 3.98 | 9224671 10589399 9664655 17551590 14991402 16925845 9125849 9142499 9211117 8800419 | |
MESH:D003711 | Demyelinating Diseases | Tamoxifen | 4.47 | 19031437 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 4.39 | 16647724 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 4.39 | 17107852 | |
MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 3.55 | 19279558 | |
MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 3.79 | 7440962 11566570 10915739 6884620 16177239 19336974 19085960 15998439 15968718 4309450 16227642 15027814 21278145 10092053 2869522 6623471 17522070 7179309 9327722 7120509 3786805 3732212 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 3.79 | 20420201 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 2.82 | 11462148 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 2.46 | 11000095 12711302 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 12.40 | 16714409 15322242 18230668 | |
MESH:D004489 | Edema, Cardiac | Tretinoin | 12.40 | 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 9.26 | 12538720 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 9.26 | 19031437 | |
MESH:D004714 | Endometrial Hyperplasia | Genistein | 4.71 | 16402032 | |
MESH:D016889 | Endometrial Neoplasms | Genistein | 12.78 | 11473722 | |
MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 12.78 | 16202921 17893378 20544844 19155303 | |
MESH:D016889 | Endometrial Neoplasms | Tretinoin | 12.78 | 16569247 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 3.10 | 9294722 10568697 | |
MESH:D004938 | Esophageal Neoplasms | nitrosobenzylmethylamine | 2.79 | 15878914 16704527 15623463 16805852 15264214 15150132 15547733 15547721 16510608 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 9.04 | 11564622 | |
MESH:D005124 | Eye Abnormalities | Tretinoin | 9.04 | 16938888 9664655 | |
MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 13.58 | 12795759 61145 15959796 19224547 12631006 16239168 16045604 17595544 | |
MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 13.58 | 15345470 | |
MESH:D005234 | Fatty Liver | Tamoxifen | 13.58 | 14986274 19224547 | |
MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 3.28 | 16709447 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 3.56 | 11858732 | |
MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 4.64 | 14745880 | |
MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 4.30 | 19069698 | |
MESH:D005355 | Fibrosis | Carbon Tetrachloride | 15.39 | 18705752 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 15.39 | 20067830 | |
MESH:D005355 | Fibrosis | Tretinoin | 15.39 | 17994277 | |
MESH:D005909 | Glioblastoma | Genistein | 7.38 | 16598420 | |
MESH:D005909 | Glioblastoma | Tretinoin | 7.38 | 17312396 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 4.73 | 10696789 | |
MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 3.24 | 16096774 | |
MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 5.29 | 16084493 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 6.67 | 10048152 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Tretinoin | 6.67 | 14991402 9664655 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 3.42 | 11000095 | |
MESH:D006505 | Hepatitis | Carbon Tetrachloride | 3.69 | 19900420 19110552 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 3.00 | 15340226 12621046 16120746 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 4.18 | 8697196 16354765 18606429 15340226 16959395 | |
MESH:D006930 | Hyperalgesia | Tretinoin | 3.28 | 16870215 | |
MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 4.65 | 16899240 | |
MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 4.67 | 16778211 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 1.93 | 18850075 18670907 | |
MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 4.19 | 15338365 | |
MESH:D007021 | Hypospadias | Ethinyl Estradiol | 3.91 | 16945680 16569931 | |
MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 3.55 | 12013081 | |
MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 2.54 | 17937319 | |
MESH:D007249 | Inflammation | Tamoxifen | 5.02 | 19457130 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 5.02 | 12200463 12878042 | |
MESH:D007333 | Insulin Resistance | bisphenol A | 3.34 | 16393666 | |
MESH:D007410 | Intestinal Diseases | Tretinoin | 3.87 | 17994277 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 10.21 | 16580747 | |
MESH:D007569 | Jaw Abnormalities | Tretinoin | 10.21 | 15992940 17551590 | |
MESH:D007674 | Kidney Diseases | ochratoxin A | 4.14 | 11409539 | |
MESH:D007680 | Kidney Neoplasms | ochratoxin A | 8.17 | 16251485 | |
MESH:D007680 | Kidney Neoplasms | Tamoxifen | 8.17 | 18625569 | |
MESH:D007938 | Leukemia | Azacitidine | 10.84 | 19148494 | |
MESH:D007938 | Leukemia | Genistein | 10.84 | 18980019 17468513 | |
MESH:D007938 | Leukemia | Tretinoin | 10.84 | 17143497 | |
MESH:D007951 | Leukemia, Myeloid | Azacitidine | 10.06 | 19077051 | |
MESH:D007951 | Leukemia, Myeloid | Tretinoin | 10.06 | 16932348 19285840 16482212 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 4.24 | 18720364 17596541 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 4.24 | 16294345 17596541 19850784 | |
MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 5.28 | 19299654 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 3.20 | 17107899 17301526 16823087 16766008 17294898 17217047 16788101 19225113 17339181 12679006 17361223 16331271 17712046 16935935 16891316 19029980 19075265 17506722 17649720 17368321 19642359 15748426 16140955 9834237 19035177 | |
MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 3.36 | 9224671 | |
MESH:D008064 | Lipidoses | Tamoxifen | 3.21 | 15342952 17567588 | |
MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 2.85 | 16239168 16943688 17174718 11408273 17334410 11903743 17157831 21278145 16221502 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 6.83 | 17565644 16638106 10355542 17481882 15650968 16248980 18279442 15338365 16027843 18054572 18187930 15996030 15959796 18277467 18156304 17869086 18429990 15818738 14716833 18412020 18263696 18395914 17766677 15931870 18418968 16136751 16011737 18472094 12667390 18210741 17640975 15673190 18317297 18472332 17976157 12586293 15876570 12546737 12609069 18376398 16192424 17761835 12632512 17805973 18395095 17922224 18339082 18251166 18420326 14748882 13678700 12632514 18205269 17714472 12445421 12898905 15052691 17557913 16116963 12445418 17631135 12649538 15362042 12958196 15123356 17708605 17525996 15730626 15893842 12741479 17721639 20821823 18166357 17900296 15370692 14512876 12666154 14724832 11481614 17944888 17698563 14716496 16097048 18006644 18705752 18481824 16015684 12389079 15925388 17823541 16033810 14620537 15057751 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 6.83 | 17823541 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 6.83 | 18564211 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 6.83 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 6.83 | 16248980 18397230 | |
MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 2.10 | 17285989 15720792 16246199 15830285 16964402 | |
MESH:D017093 | Liver Failure | Carbon Tetrachloride | 4.27 | 15123358 | |
MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 3.77 | 16899240 14706259 | |
MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 7.56 | 19294768 | |
MESH:D008113 | Liver Neoplasms | Tamoxifen | 7.56 | 16684651 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 7.56 | 16984957 | |
MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 5.92 | 12014681 15583823 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 5.92 | 12151625 | |
MESH:D008175 | Lung Neoplasms | Azacitidine | 3.54 | 21224363 | |
MESH:D008175 | Lung Neoplasms | Tamoxifen | 3.54 | 18625569 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 3.54 | 11884234 19555203 | |
MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 3.88 | 19428831 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 10.49 | 12929590 14578162 | |
MESH:D008325 | Mammary Neoplasms, Experimental | ochratoxin A | 10.49 | 11921183 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 10.49 | 11731420 19196723 19196722 14580682 16827153 | |
MESH:D020149 | Manganese Poisoning | Tamoxifen | 4.68 | 19453300 | |
MESH:D008527 | Medulloblastoma | Tretinoin | 2.81 | 17453147 | |
MESH:D008545 | Melanoma | Tamoxifen | 3.33 | 19393235 12393984 | |
MESH:D008545 | Melanoma | Tretinoin | 3.33 | 16752155 | |
MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 4.30 | 15990972 | |
MESH:D008591 | Meningomyelocele | Tretinoin | 4.53 | 16940565 | |
MESH:D008850 | Microphthalmos | ochratoxin A | 5.89 | 20036863 | |
MESH:D009006 | Monosomy | Azacitidine | 6.22 | 19299654 | |
MESH:D009101 | Multiple Myeloma | Azacitidine | 4.02 | 18443271 19549372 | |
MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 7.85 | 17596541 19805378 17611569 18720364 | |
MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 7.85 | 17596541 | |
MESH:D009203 | Myocardial Infarction | Genistein | 2.89 | 17141266 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 3.08 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 3.72 | 17141266 | |
MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 2.57 | 19393235 | |
MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 2.54 | 19410462 | |
MESH:D009369 | Neoplasms | Tretinoin | 2.44 | 16594593 16946489 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 4.13 | 19200415 19189210 19196722 | |
MESH:D009421 | Nervous System Malformations | bisphenol A | 24.29 | 11399458 16427766 | |
MESH:D009421 | Nervous System Malformations | Genistein | 24.29 | 16427766 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 24.29 | 14600291 | |
MESH:D009421 | Nervous System Malformations | Tretinoin | 24.29 | 9125849 | |
MESH:D009436 | Neural Tube Defects | ochratoxin A | 7.96 | 20036863 | |
MESH:D009436 | Neural Tube Defects | Tretinoin | 7.96 | 9142499 | |
MESH:D010024 | Osteoporosis | Genistein | 3.30 | 19401787 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 4.17 | 16169203 | |
MESH:D010049 | Ovarian Diseases | bisphenol A | 5.11 | 11985600 | |
MESH:D010051 | Ovarian Neoplasms | Genistein | 5.02 | 19005980 | |
MESH:D010051 | Ovarian Neoplasms | Tretinoin | 5.02 | 16936753 | |
MESH:D010146 | Pain | Tretinoin | 2.97 | 16870215 | |
MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 2.49 | 15976015 | |
MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 3.77 | 11578682 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 4.38 | 12520081 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 3.65 | 18163543 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 9.90 | 10548101 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 9.90 | 11896295 11399792 11118676 11222880 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 4.29 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | Azacitidine | 2.12 | 18324645 | |
MESH:D011471 | Prostatic Neoplasms | bisphenol A | 2.12 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Genistein | 2.12 | 15256057 16925846 15378649 | |
MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 2.12 | 15067354 | |
MESH:D011507 | Proteinuria | Tretinoin | 3.69 | 16636307 | |
MESH:D011537 | Pruritus | Ethinyl Estradiol | 3.43 | 16919318 15861022 | |
MESH:D011625 | Pterygium | Tretinoin | 4.91 | 16723453 | |
MESH:D011629 | Puberty, Precocious | bisphenol A | 4.90 | 10548101 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.93 | 18990726 | |
MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 4.19 | 16116481 16283617 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 5.68 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tretinoin | 5.68 | 16467112 | |
MESH:D013088 | Spermatocele | Ethinyl Estradiol | 12.01 | 16709447 | |
MESH:D013088 | Spermatocele | Tamoxifen | 12.01 | 16709447 | |
MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 4.15 | 19457130 | |
MESH:D013274 | Stomach Neoplasms | nitrosobenzylmethylamine | 2.65 | 12958204 17575124 | |
MESH:D013274 | Stomach Neoplasms | Tretinoin | 2.65 | 17261132 | |
MESH:D019966 | Substance-Related Disorders | bisphenol A | 4.10 | 16045194 16684133 | |
MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 3.71 | 11994571 | |
MESH:D013927 | Thrombosis | Ethinyl Estradiol | 3.22 | 15669648 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 4.04 | 12697716 | |
MESH:D013964 | Thyroid Neoplasms | Tretinoin | 3.09 | 16026305 17045167 | |
MESH:D014062 | Tongue Neoplasms | Tretinoin | 3.86 | 16051514 | |
MESH:D014376 | Tuberculosis | Tretinoin | 3.27 | 16040207 | |
MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 2.38 | 16712894 17572228 8653321 | |
MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 3.75 | 16129372 | |
MESH:D014591 | Uterine Diseases | bisphenol A | 5.14 | 14652134 | |
MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 3.39 | 14692618 | |
MESH:D014604 | Uveal Neoplasms | Tretinoin | 4.74 | 16752155 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 4.73 | 12125929 | |
MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 3.62 | 14671159 15869587 | |
MESH:D014820 | Vitiligo | Tretinoin | 4.15 | 16761959 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 4.38 | 15886252 | |
MESH:D009396 | Wilms Tumor | Tretinoin | 4.04 | 16287080 |
No data |